Muheez A. Durosinmi

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon et al. · JNCI Journal of the National Cancer Institute · 2011 · 428 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +15

Disease Features in Acute Myeloid Leukemia with t(8;21)(q22;q22). Influence of Age, Secondary Karyotype Abnormalities, CD19 Status, and Extramedullar Leukemia on Survival

G. John Swansbury, Ayad Atra, C Horton et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 72 citations

Medicine, Hematology, Oncology +17

Treatment of Burkitt lymphoma in equatorial Africa using a simple three‐drug combination followed by a salvage regimen for patients with persistent or recurrent disease

Twalib Ngoma, Melissa Adde, Muheez A. Durosinmi et al. · British Journal of Haematology · 2012 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

The Search for a Predictor of CD4 Cell Count Continues: Total Lymphocyte Count Is Not a Substitute for CD4 Cell Count in the Management of HIV-Infected Individuals in a Resource-Limited Setting

N O Akinola, Olayinka Olasode, I A Adediran et al. · Clinical Infectious Diseases · 2004 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +8

Insecticide residues in the blood serum and domestic water source of cacao farmers in Southwestern Nigeria

Mosudi Babatunde Sosan, A. E. Akingbohungbe, I. A. O. Ojo et al. · Chemosphere · 2008 · 57 citations

Veterinary Medicine, Environmental Sciences, Toxicology +15